Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2008-07-01
2008-07-01
Aulakh, Charanjit S. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S016000, C548S409000, C548S950000, C514S409000
Reexamination Certificate
active
10548678
ABSTRACT:
The present invention relates to compounds of formula (Ia)wherein A, B, n, m, R1, R2, R3, R4, R5, R6, R7, R8, R9, R10and R11are defined herein, and pharmaceutically acceptable salts thereof; the compounds are of particular use in the treatment or prevention of depression, anxiety, pain, inflammation, migraine, emesis or postherpetic neuralgia.
REFERENCES:
patent: WO 00/56727 (2000-09-01), None
patent: WO 00/56728 (2000-09-01), None
patent: WO 02/16343 (2002-02-01), None
patent: WO 02/16344 (2002-02-01), None
patent: WO 03/022839 (2003-03-01), None
patent: WO 2004/009573 (2004-01-01), None
patent: WO 2004/078750 (2004-09-01), None
Physicians' Desk Reference, 2007, pp. 1963-1969, 61st Edition, Montvale, New Jersey.
Dirat Olivier
Elliott Jason Matthew
Huscroft Ian Thomas
Jelley Richard Alexander
Kulagowski Janusz Jozef
Aulakh Charanjit S.
Camara Valerie J.
Merck Sharp & Dohme Ltd.
Panzer Curtis C.
LandOfFree
Tetrahydropyran compounds as tachykinin antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tetrahydropyran compounds as tachykinin antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tetrahydropyran compounds as tachykinin antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3950652